WHAT IS BPC-157?

BPC-157 stands for Body Protection Compound-157. It’s a synthetic peptide consisting of 15 amino acids, derived from a larger protective protein naturally found in human gastric juice. Researchers classify it as a “stable gastric pentadecapeptide” because of its unusual stability in the harsh acidic environment of the stomach.

BPC-157 was originally isolated and studied by Dr. Predrag Sikiric’s research group at the University of Zagreb, Croatia, beginning in the early 1990s. Since then, over 100 peer-reviewed studies have been published examining its effects on tissue healing, inflammation, and organ protection. The vast majority of this research has been conducted in animal models.

The peptide works through several mechanisms: it upregulates growth factor expression, promotes angiogenesis, modulates the nitric oxide system, and supports the FAK-paxillin pathway, which governs cell migration to damaged tissue. The consistency of results across multiple tissue types and over 100 studies is what makes BPC-157 notable in the peptide landscape.

Unlike many compounds in the optimization world, BPC-157 isn’t about performance enhancement or body composition – BPC 157 is a repair molecule. The research points to a compound that helps the body heal faster and more completely from injury.
BPC 157 will be reviewed by the FDA Compounding Advisory Committee in July 2026 to see if it will allow the peptide to be produced by licensed compounding pharmacies.